$ACAN
AmeriCann, Inc.

2024 Q2 Form 10-Q Financial Statement

#000143774924016535 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $172.8K $453.7K
YoY Change -70.36% -39.38%
Cost Of Revenue $390.00 $0.00
YoY Change
Gross Profit $172.4K $453.7K
YoY Change -70.43% -39.38%
Gross Profit Margin 99.78% 100.0%
Selling, General & Admin $505.1K $498.6K
YoY Change 11.19% 4.04%
% of Gross Profit 293.0% 109.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $115.6K $115.6K
YoY Change -0.01% 1.99%
% of Gross Profit 67.04% 25.47%
Operating Expenses $505.1K $498.6K
YoY Change 11.19% 4.03%
Operating Profit -$332.7K -$44.93K
YoY Change -358.56% -116.69%
Interest Expense -$125.5K -$121.2K
YoY Change -32.0% -33.63%
% of Operating Profit
Other Income/Expense, Net -$125.5K -$121.2K
YoY Change -32.0% -33.62%
Pretax Income -$458.2K -$166.1K
YoY Change 719.26% -291.75%
Income Tax
% Of Pretax Income
Net Earnings -$458.2K -$166.1K
YoY Change 719.32% -291.74%
Net Earnings / Revenue -265.23% -36.61%
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 24.39M 24.39M
Diluted Shares Outstanding 24.39M 24.39M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.6K $513.4K
YoY Change -84.87% -59.02%
Cash & Equivalents $210.6K $513.4K
Short-Term Investments
Other Short-Term Assets $37.57K $50.13K
YoY Change 12.82% 15.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $948.4K $1.267M
YoY Change -42.66% -20.06%
LONG-TERM ASSETS
Property, Plant & Equipment $13.08M $13.22M
YoY Change -3.9% -3.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.37M $13.52M
YoY Change -1.8% -1.32%
TOTAL ASSETS
Total Short-Term Assets $948.4K $1.267M
Total Long-Term Assets $13.37M $13.52M
Total Assets $14.32M $14.79M
YoY Change -6.22% -3.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $61.25K $73.20K
YoY Change -23.13% -14.07%
Accrued Expenses $66.68K $59.18K
YoY Change 26.65% 10.04%
Deferred Revenue
YoY Change
Short-Term Debt $5.082M $5.082M
YoY Change 13.33% 14.58%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.213M $5.221M
YoY Change 12.73% 13.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $4.195M $4.198M
YoY Change -0.31% -0.3%
Total Long-Term Liabilities $4.195M $4.198M
YoY Change -12.42% -12.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.213M $5.221M
Total Long-Term Liabilities $4.195M $4.198M
Total Liabilities $9.407M $9.419M
YoY Change -0.06% 0.47%
SHAREHOLDERS EQUITY
Retained Earnings -$20.65M -$20.19M
YoY Change 4.79% 2.76%
Common Stock $2.439K $2.439K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.911M $5.369M
YoY Change
Total Liabilities & Shareholders Equity $14.32M $14.79M
YoY Change -6.22% -3.26%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$458.2K -$166.1K
YoY Change 719.32% -291.74%
Depreciation, Depletion And Amortization $115.6K $115.6K
YoY Change -0.01% 1.99%
Cash From Operating Activities -$318.6K -$314.5K
YoY Change -284.28% -294.75%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $15.76K $20.28K
YoY Change 24.19% 100.4%
Cash From Investing Activities $15.76K $20.28K
YoY Change -146.67% -111.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -318.6K -314.5K
Cash From Investing Activities 15.76K 20.28K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -302.8K -294.2K
YoY Change -317.69% 1338.48%
FREE CASH FLOW
Cash From Operating Activities -$318.6K -$314.5K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$318.6K -$314.5K
YoY Change -352.01% 928.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20191534 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5369267 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5707357 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14788169 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15154894 usd
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
453655 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
748406 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1133 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
453655 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
748406 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4475 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3953 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
116112 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
83339 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
377999 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
391957 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
498586 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
479249 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-44931 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
269157 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15303 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-121160 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-182535 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-166091 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5802112 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5824857 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5911479 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5707357 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-171999 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5535358 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-166091 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5369267 usd
us-gaap Net Income Loss
NetIncomeLoss
-338090 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
231124 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
225794 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34969 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34510 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
97412 usd
acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
534316 usd
acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
16193 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
16742 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-29433 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14051 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-107982 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5990 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5532 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5802 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-11922 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
604 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
345 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-651690 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
272732 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
-0 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
32705 usd
acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
-0 usd
acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
200000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
30131 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
21717 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30131 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210988 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-621559 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-88256 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1144973 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
523414 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1262838 usd
us-gaap Interest Paid Net
InterestPaidNet
269718 usd
us-gaap Interest Paid Net
InterestPaidNet
285010 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
513447 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1135006 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523414 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1144973 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8206888 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8206888 usd
us-gaap Depreciation
Depreciation
231124 usd
us-gaap Depreciation
Depreciation
225794 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20191534 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2024Q1 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.12 pure
CY2023Q3 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.12 pure
acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
8898 usd
CY2023 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
8898 usd
CY2024Q1 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
369869 usd
CY2023Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
400000 usd
CY2024Q1 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
-65937 usd
CY2023Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
-62116 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
303932 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
337884 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-166091 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
us-gaap Net Income Loss
NetIncomeLoss
-338090 usd
us-gaap Net Income Loss
NetIncomeLoss
109367 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957 usd
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6673874 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12693 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4197910 usd
acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
170757 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P42Y6M
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
170743 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500 usd
CY2024Q1 acan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
12977000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14513743 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10303140 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4210603 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12693 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4197910 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
240688 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
240688 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y4M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2148000
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.33
CY2023 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y1M17D
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2148000
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.33
acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P0Y7M17D
CY2024Q1 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2148000
CY2024Q1 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.33
acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P0Y7M17D

Files In Submission

Name View Source Status
0001437749-24-016535-index-headers.html Edgar Link pending
0001437749-24-016535-index.html Edgar Link pending
0001437749-24-016535.txt Edgar Link pending
0001437749-24-016535-xbrl.zip Edgar Link pending
acan-20240331.xsd Edgar Link pending
acan20240331_10q.htm Edgar Link pending
ex_667917.htm Edgar Link pending
ex_667918.htm Edgar Link pending
ex_667919.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
acan-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acan20240331_10q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acan-20240331_def.xml Edgar Link unprocessable
acan-20240331_cal.xml Edgar Link unprocessable
acan-20240331_lab.xml Edgar Link unprocessable